Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Patches After Cesarean Section
NCT04443569Phase 3Completed
- Sponsor
- Yale University
- Start
- Oct 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lidocaine 10% oropharyngeal spray in postoperative pain (2 arms), sponsored by Yale University. Primary endpoint: Visual Analog Pain Score at 72 hours. Started Oct 2021; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04443569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04443569.